Cardiac thromboxane A2 receptor activation does not directly induce cardiomyocyte hypertrophy but does cause cell death that is prevented with gentamicin and 2-APB-Reference-Cited by-同舟云学术

Cardiac thromboxane A2 receptor activation does not directly induce cardiomyocyte hypertrophy but does cause cell death that is prevented with gentamicin and 2-APB

Published:2014-12 Issue:1 Volume:15 Page:
ISSN:2050-6511
Container-title:BMC Pharmacology and Toxicology
language:en
Short-container-title:BMC Pharmacol Toxicol

Author:

Touchberry Chad D,Silswal Neerupma,Tchikrizov Vladimir,Elmore Christopher J,Srinivas Shubra,Akthar Adil S,Swan Hannah K,Wetmore Lori A,Wacker Michael J

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1186/2050-6511-15-73.pdf

Reference68 articles.

1. Graziani F, Biasucci LM, Cialdella P, Liuzzo G, Giubilato S, Della Bona R, Pulcinelli FM, Iaconelli A, Mingrone G, Crea F: Thromboxane production in morbidly obese subjects. Am J Cardiol. 2011, 107: 1656-1661. 10.1016/j.amjcard.2011.01.053.

2. Takayama K, Yuhki K, Ono K, Fujino T, Hara A, Yamada T, Kuriyama S, Karibe H, Okada Y, Takahata O, Taniguchi T, Iijima T, Iwasaki H, Narumiya S, Ushikubi F: Thromboxane A2 and prostaglandin F2alpha mediate inflammatory tachycardia. Nat Med. 2005, 11: 562-566. 10.1038/nm1231.

3. Coker SJ, Parratt JR, Ledingham IM, Zeitlin IJ: Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias. Nature. 1981, 291: 323-324. 10.1038/291323a0.

4. Hirsh PD, Hillis LD, Campbell WB, Firth BG, Willerson JT: Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med. 1981, 304: 685-691. 10.1056/NEJM198103193041201.

5. Montalescot G, Drobinski G, Maclouf J, Maillet F, Salloum J, Ankri A, Kazatchkine M, Eugene L, Thomas D, Grosgogeat Y: Evaluation of thromboxane production and complement activation during myocardial ischemia in patients with angina pectoris. Circulation. 1991, 84: 2054-2062. 10.1161/01.CIR.84.5.2054.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostacyclin Synthase Deficiency Leads to Exacerbation or Occurrence of Endothelium-Dependent Contraction and Causes Cardiovascular Disorders Mainly via the Non-TxA ₂ Prostanoids/TP Axis;Circulation Research;2024-08-30

2. Adjustment for Renal Function Improves the Prognostic Performance of Urinary Thromboxane Metabolites;Clinical Chemistry;2024-02-28

3. Doxorubicin alters G-protein coupled receptor-mediated vasocontraction in rat coronary arteries;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-02-08

4. Doxorubicin alters G-protein coupled receptor-mediated vasocontraction in rat coronary arteries;2023-12-07

5. Gemcitabine resistance in non‐small cell lung cancer is mediated through activation of the PI3K/AKT/NF‐κB pathway and suppression of ERK signaling by reactive oxygen species;Journal of Biochemical and Molecular Toxicology;2023-08-11